RT Journal Article
SR Electronic
T1 601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A684
OP A684
DO 10.1136/jitc-2023-SITC2023.0601
VO 11
IS Suppl 1
A1 Lu, Tianshi
A1 Socinski, Mark A
A1 Reck, Martin
A1 West, Howard
A1 Cappuzzo, Federico
A1 Barlesi, Fabrice
A1 Jotte, Robert M
A1 Müller, Sören
A1 Hamidi, Habib
A1 Amitai, Assaf
A1 Koeppen, Hartmut
A1 Shames, David S
A1 Ballinger, Marcus
A1 Qamra, Aditi
A1 Srivastava, Minu K
A1 Nabet, Barzin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A684.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.